Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Video Library
Search the Video Library
Filter by Cancer Type:
Displaying Results 1 - 1 of 1